
### [NCIT:C4830](http://purl.obolibrary.org/obo/NCIT_C4830)
**Label:** Ureter Urothelial Carcinoma

**Subclasses:** [NCIT:C6149](http://purl.obolibrary.org/obo/NCIT_C6149) (Stage 0 Ureter Urothelial Carcinoma), [NCIT:C6203](http://purl.obolibrary.org/obo/NCIT_C6203) (Stage 0a Ureter Urothelial Carcinoma), [NCIT:C6156](http://purl.obolibrary.org/obo/NCIT_C6156) (Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation), [NCIT:C6157](http://purl.obolibrary.org/obo/NCIT_C6157) (Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation), [NCIT:C4529](http://purl.obolibrary.org/obo/NCIT_C4529) (Stage 0is Ureter Urothelial Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.58%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) 45.82%
- [NCIT:C36767](http://purl.obolibrary.org/obo/NCIT_C36767) (Abnormal Transitional Cell) 45.82%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C38971](http://purl.obolibrary.org/obo/NCIT_C38971) (Regulation of Apoptosis Pathway))) 45.82%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C3892](http://purl.obolibrary.org/obo/NCIT_C3892) (Mu Heavy Chain Disease))) 45.82%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C38850](http://purl.obolibrary.org/obo/NCIT_C38850) (Phosphatidylinositol Signaling System Pathway))) 45.82%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C38834](http://purl.obolibrary.org/obo/NCIT_C38834) (MAPK Signaling Pathway))) 45.82%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C38829](http://purl.obolibrary.org/obo/NCIT_C38829) (Focal Adhesion Pathway))) 45.82%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C38828](http://purl.obolibrary.org/obo/NCIT_C38828) (Inositol Phosphate Metabolism Pathway))) 45.82%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C3880](http://purl.obolibrary.org/obo/NCIT_C3880) (Eyelid Nevus))) 45.82%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C38784](http://purl.obolibrary.org/obo/NCIT_C38784) (Apoptosis Pathway))) 45.82%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C38770](http://purl.obolibrary.org/obo/NCIT_C38770) (Squamous Differentiation))) 45.82%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C38762](http://purl.obolibrary.org/obo/NCIT_C38762) (Thyroid Gland Mucoepidermoid Carcinoma))) 45.82%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C3876](http://purl.obolibrary.org/obo/NCIT_C3876) (Gastric Leiomyoma))) 45.82%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C38759](http://purl.obolibrary.org/obo/NCIT_C38759) (EBV Infection))) 45.82%


